Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.

Moderna people hold a deep sense of responsibility for each other, patients, the environment and our local communities. Our people live our Values every day.

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Nov 8, 2024 · mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve mRESVIA following approvals in the U.S., Europe, and Qatar

Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.

Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.

Resources for journalists and media members. The latest press releases by Moderna.

Online: Moderna's Adverse Event Intake Portal or U.S. HHS's Vaccine Adverse Event Reporting System. Connect with us. Email: [email protected] Call: 1-866-MODERNA (1-866-663-3762) Monday - Friday 8:00 AM to 8:00 PM ET (closed holidays)